METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES

Bibliográfalaš dieđut
Váldodahkkit:	Kitley, J, Elsone, L, George, J, Jacob, A, Leite, M, Palace, J
Materiálatiipa:	Conference item
Almmustuhtton:	2012

Geahča maid

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Dahkki: Kitley, J, et al.
Almmustuhtton: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
Dahkki: Elsone, L, et al.
Almmustuhtton: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
Dahkki: Kitley, J, et al.
Almmustuhtton: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
Dahkki: Waters, P, et al.
Almmustuhtton: (2015)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Dahkki: Paul, F, et al.
Almmustuhtton: (2007)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
Dahkki: Kitley, J, et al.
Almmustuhtton: (2013)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
Dahkki: Waters, P, et al.
Almmustuhtton: (2008)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Dahkki: Waters, P, et al.
Almmustuhtton: (2016)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2014)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Dahkki: Elsone, L, et al.
Almmustuhtton: (2014)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
Dahkki: Palace, J, et al.
Almmustuhtton: (2010)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
Dahkki: Elsone, L, et al.
Almmustuhtton: (2013)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Dahkki: Kitley, J, et al.
Almmustuhtton: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2014)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
Dahkki: Leite, M, et al.
Almmustuhtton: (2009)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Dahkki: Kitley, J, et al.
Almmustuhtton: (2014)

Use of mitoxantrone in neuromyelitis optica.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2011)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Dahkki: Nour, M, et al.
Almmustuhtton: (2015)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Dahkki: Kitley, J, et al.
Almmustuhtton: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2012)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
Dahkki: Wilson, R, et al.
Almmustuhtton: (2018)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
Dahkki: Cheng, F, et al.
Almmustuhtton: (2014)

Seasonal pattern of variation in neuromyelitis optica relapses
Dahkki: Elsone, L, et al.
Almmustuhtton: (2012)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
Dahkki: Akman-Demir, G, et al.
Almmustuhtton: (2011)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Dahkki: Kim, S, et al.
Almmustuhtton: (2013)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
Dahkki: Elsone, L, et al.
Almmustuhtton: (2013)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Dahkki: Pittock, S, et al.
Almmustuhtton: (2019)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
Dahkki: Cavus, F, et al.
Almmustuhtton: (2013)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
Dahkki: Waters, P, et al.
Almmustuhtton: (2008)

Distinction of aquaporin-4 antibody positive neuromyelitis optica from multiple sclerosis using diffusion tensor and myelin water imaging
Dahkki: Matthews, L, et al.
Almmustuhtton: (2011)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
Dahkki: Min, J, et al.
Almmustuhtton: (2010)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Dahkki: Kitley, J, et al.
Almmustuhtton: (2012)

A practical guide to the treatment of neuromyelitis optica.
Dahkki: Palace, J, et al.
Almmustuhtton: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Dahkki: Collongues, N, et al.
Almmustuhtton: (2013)